Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes

J L Wautier, G M Tobelem, A P Peltier

    Pathologie-Biologie
    |December 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endothelial cells in culture: a model to study in vitro vascular toxicity.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.

    International journal of molecular medicine·2009
    Same author

    Postprandial hyperglycemia alters inflammatory and hemostatic parameters.

    Diabetes & metabolism·2007
    Same author

    [Andragogy: reality or utopy].

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2004
    Same author

    N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.

    Diabetes & metabolism·2003
    Same author

    A new dark side of the Maillard's products.

    Diabetes & metabolism·2003
    Same journal

    Pathologie-biologie·2020
    Same journal

    Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

    Pathologie-biologie·2015
    Same journal

    [Not Available].

    Pathologie-biologie·2015
    Same journal

    Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

    Pathologie-biologie·2015
    Same journal

    Biological diagnosis of diabetes mellitus.

    Pathologie-biologie·2015
    Same journal

    Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

    Pathologie-biologie·2015
    See all related articles

    Chronic lymphocytic leukemia (CLL) patients show reduced platelet C1 levels and impaired platelet aggregation. CLL lymphocytes inhibit platelet C1 and aggregation more than normal lymphocytes.

    Area of Science:

    • Immunology
    • Hematology
    • Biochemistry

    Background:

    • Platelet C1 plays a role in immune interactions.
    • Chronic lymphocytic leukemia (CLL) is a hematological malignancy affecting lymphocytes.

    Purpose of the Study:

    • To investigate platelet C1 levels and function in CLL patients.
    • To explore the inhibitory effect of CLL lymphocytes on platelet C1 and aggregation.

    Main Methods:

    • Hemolytic method to evaluate platelet C1 levels.
    • Platelet aggregation assays using aggregated IgG and anti-C1q antisera.
    • In vitro studies comparing CLL lymphocytes with normal lymphocytes.

    Main Results:

    • Platelet C1 levels were significantly low in CLL patients.

    Related Experiment Videos

  • Platelet aggregation induced by aggregated IgG or anti-C1q was reduced in CLL.
  • CLL lymphocytes demonstrated enhanced inhibition of platelet C1 and aggregation compared to normal lymphocytes.

    • Conclusions:

    • Platelet C1 dysfunction may be implicated in CLL pathogenesis.
    • CLL lymphocytes actively inhibit platelet C1 and aggregation, suggesting a role in immune modulation.
    • Further research is needed to elucidate the precise mechanisms of platelet-immunoglobulin interactions in CLL.